Crystalvue Medical Corporation announces an Equity Buyback for 800,000 shares, representing 3.73% of its issued share capital.

Crystalvue Medical Corporation (GTSM:6527) announces a share repurchase program. Under the program, the company will repurchase up to 800,000 shares, representing 3.73% of its issued share capital. The shares will be repurchased at a price in the range of TWD 23 to TWD 38 per share. The repurchase program will expire on May 5, 2018.